BrainStorm Therapeutics,

This company accelerates CNS drug discovery by utilizing patient-derived brain organoids to model complex neurological disorders. They employ biomarker-based screening and advanced data analytics to generate human efficacy and safety data early in the R&D process. This approach aims to de-risk clinical translation and improve the development of breakthrough medicines for challenging brain diseases.

Traction 5/10

San Diego, United States · HQ

Founded 20237300+ followers

Biotechnology

Updated 6 months ago

Funding

Funding rounds are not available yet.

Founders

2 founders

Maya Gosztyla

Co-Founder & Lead Scientist

Jun Yin

Entrepreneur | Drug Development from Discovery to Clinical | AI Foundation Model | Computational Infrastructure and Bioinformatics

Product

Features

This company accelerates CNS drug discovery by utilizing patient-derived brain organoids to model complex neurological disorders. They employ biomarker-based screening and advanced data analytics to generate human efficacy and safety data early in the R&D process. This approach aims to de-risk clinical translation and improve the development of breakthrough medicines for challenging brain diseases.